Improving the Capture of Adverse Event Data in Clinical Trials: The Role of the International Atomic Energy Agency-Reference-Cited by-同舟云学术

Improving the Capture of Adverse Event Data in Clinical Trials: The Role of the International Atomic Energy Agency

Published:2007-11 Issue:4 Volume:69 Page:1218-1221
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Davidson Susan E.,Trotti Andy,Ataman Özlem U.,Seong Jinsil,Lau Fen Nee,da Motta Neiro W.,Jeremic Branislav

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference24 articles.

1. Adverse event reporting and developments in radiation biology after normal tissue injury: International Atomic Energy Agency consultation;Chen;Int J Radiat Oncol Biol Phys,2006

2. Towards evidence based radiation oncology: Improving the design, analysis, and reporting of clinical outcome studies in radiotherapy;Bentzen;Radiother Oncol,1998

3. National Cancer Institute. CTC v2.0 and common terminology criteria for adverse events v3.0 (CTCAE). Available at: http://ctep.cancer.gov/reporting/ctc.html. Accessed May 6, 2007.

4. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma;Denis;J Clin Oncol,2004

5. Assessment of toxicity in cooperative oncology clinical trials: The long and short of it;Gwede;J Oncol Manag,2002

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electronic self-reporting of adverse events for patients undergoing cancer treatment: the eRAPID research programme including two RCTs;Programme Grants for Applied Research;2022-02

2. The adverse effects of bisphosphonates in breast cancer: A systematic review and network meta-analysis;PLOS ONE;2021-02-05

3. Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial;Radiotherapy and Oncology;2019-05

4. Bowel morbidity following radiochemotherapy and image-guided adaptive brachytherapy for cervical cancer: Physician- and patient reported outcome from the EMBRACE study;Radiotherapy and Oncology;2018-06

5. Comparative assessment of late toxicity in patients of carcinoma cervix treated by radiotherapy versus chemo-radiotherapy – Minimum 5 years follow up;Cancer Treatment and Research Communications;2018